These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 6172710)

  • 1. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.
    Embury SH; Dozy AM; Miller J; Davis JR; Kleman KM; Preisler H; Vichinsky E; Lande WN; Lubin BH; Kan YW; Mentzer WC
    N Engl J Med; 1982 Feb; 306(5):270-4. PubMed ID: 6172710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of alpha-thalassemia and homozygous sickle-cell disease.
    Higgs DR; Aldridge BE; Lamb J; Clegg JB; Weatherall DJ; Hayes RJ; Grandison Y; Lowrie Y; Mason KP; Serjeant BE; Serjeant GR
    N Engl J Med; 1982 Jun; 306(24):1441-6. PubMed ID: 6176865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.
    Noguchi CT; Dover GJ; Rodgers GP; Serjeant GR; Antonarakis SE; Anagnou NP; Higgs DR; Weatherall DJ; Schechter AN
    J Clin Invest; 1985 May; 75(5):1632-7. PubMed ID: 2581999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.
    Perrine SP; Ginder GD; Faller DV; Dover GH; Ikuta T; Witkowska HE; Cai SP; Vichinsky EP; Olivieri NF
    N Engl J Med; 1993 Jan; 328(2):81-6. PubMed ID: 7677966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytes.
    Embury SH; Clark MR; Monroy G; Mohandas N
    J Clin Invest; 1984 Jan; 73(1):116-23. PubMed ID: 6690472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Hb F and alpha-thalassemia on the red cell indices in sickle cell anemia.
    Milner PF; Garbutt GJ; Nolan-Davis LV; Jonah F; Wilson LB; Wilson JT
    Am J Hematol; 1986 Apr; 21(4):383-95. PubMed ID: 2420172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type.
    Nagel RL; Fabry ME; Pagnier J; Zohoun I; Wajcman H; Baudin V; Labie D
    N Engl J Med; 1985 Apr; 312(14):880-4. PubMed ID: 2579336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alpha-thalassemia-2 on the developmental changes of hematological values in children with sickle cell disease from Georgia.
    Felice AE; McKie KM; Cleek MP; Marino EM; Kutlar A; McKie VC
    Am J Hematol; 1987 Aug; 25(4):389-400. PubMed ID: 2441597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of sickle cell disease as shown by density profiles: effects of fetal hemoglobin and alpha thalassemia.
    Baudin V; Pagnier J; Labie D; Girot R; Wajcman H
    Haematologia (Budap); 1986; 19(3):177-84. PubMed ID: 2430866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of influence of fetal hemoglobin levels or erythrocyte indices on the severity of sickle cell anemia.
    Powars DR; Schroeder WA; Weiss JN; Chan LS; Azen SP
    J Clin Invest; 1980 Mar; 65(3):732-40. PubMed ID: 6153392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain in sickle cell disease. Rates and risk factors.
    Platt OS; Thorington BD; Brambilla DJ; Milner PF; Rosse WF; Vichinsky E; Kinney TR
    N Engl J Med; 1991 Jul; 325(1):11-6. PubMed ID: 1710777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foetal haemoglobin levels in sickle cell anaemia in Nigerians.
    Falusi AG; Esan GJ
    Afr J Med Med Sci; 1989 Jun; 18(2):145-9. PubMed ID: 2474239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of hemoglobin H disease by sickle trait.
    Matthay KK; Mentzer WC; Dozy AM; Kan YW; Bainton DF
    J Clin Invest; 1979 Oct; 64(4):1024-32. PubMed ID: 479366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of alpha-thalassemia and beta-globin gene cluster haplotypes on the hematological and clinical features of sickle-cell anemia in Brazil.
    Figueiredo MS; Kerbauy J; Gonçalves MS; Arruda VR; Saad ST; Sonati MF; Stoming T; Costa FF
    Am J Hematol; 1996 Oct; 53(2):72-6. PubMed ID: 8892730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What determines severity in sickle-cell disease?
    Schechter AN; Bunn HF
    N Engl J Med; 1982 Feb; 306(5):295-7. PubMed ID: 6172711
    [No Abstract]   [Full Text] [Related]  

  • 17. Sickle cell syndromes. I. Hemoglobin SC-alpha-thalassemia.
    Honig GR; Gunay U; Mason RG; Vida LN; Ferenc C
    Pediatr Res; 1976 Jun; 10(6):613-20. PubMed ID: 1272638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Thalassemia and HbF concentration in sickle cell anemia.
    Rucknagel D; Ferrucci S; Whitten CF; Sarniak I; Odenheimer D; Sing C; Bruzdzinski C
    Prog Clin Biol Res; 1984; 165():103-20. PubMed ID: 6209727
    [No Abstract]   [Full Text] [Related]  

  • 19. Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies.
    Sher GD; Ginder GD; Little J; Yang S; Dover GJ; Olivieri NF
    N Engl J Med; 1995 Jun; 332(24):1606-10. PubMed ID: 7753139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cellular basis for different fetal hemoglobin levels among sickle cell individuals with two, three, and four alpha-globin genes.
    Dover GJ; Chang VT; Boyer SH; Serjeant GR; Antonarakis S; Higgs DR
    Blood; 1987 Jan; 69(1):341-4. PubMed ID: 2431731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.